Detalhe da pesquisa
1.
Pembrolizumab for advanced non-small cell lung cancer (NSCLC): Impact of autoimmune comorbidity and outcomes following treatment completion.
J Oncol Pharm Pract
; 29(4): 785-793, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167399
2.
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
Lancet Oncol
; 22(11): 1530-1540, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34656227
3.
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.
Br J Cancer
; 125(9): 1210-1216, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489586
4.
Case report: immune-mediated cerebellar ataxia secondary to anti-PD-L1 treatment for lung cancer.
Int J Neurosci
; 129(12): 1223-1225, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31414604
5.
SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting.
Br J Cancer
; 117(7): 938-946, 2017 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950288
6.
Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial.
Lung Cancer
; 171: 26-33, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35872530
7.
A phase 1 pharmacokinetic and pharmacodynamic study of the histone deacetylase inhibitor belinostat in patients with advanced solid tumors.
Clin Cancer Res
; 14(3): 804-10, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18245542
8.
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032.
J Thorac Oncol
; 14(2): 237-244, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30316010
9.
CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial.
Trials
; 19(1): 233, 2018 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669604
10.
Carcinoembryonic antigen (CEA) testing in colorectal cancer follow up: what do patients think?
Postgrad Med J
; 83(983): 612-4, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17823231
11.
Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial.
J Clin Oncol
; 35(31): 3591-3600, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28892431
12.
Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: an expert consensus.
Lung Cancer
; 87(2): 89-95, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25576294
13.
Are patients in clinical trials representative of the general population? Dose intensity and toxicities associated with FE100C-D chemotherapy in a non-trial population of node positive breast cancer patients compared with PACS-01 trial group.
Eur J Cancer
; 47(2): 215-20, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21094038